P

Phaxiam TherapeuticsBiotechnology · 51-200 · B2B contacts & data

Biotechnology France B2B Est. 2004
4 Decision makers
200 Employees
2004 Founded

Decision Makers at Phaxiam Therapeutics

Total identified

4 decision makers identified 1 C-Level 3 VP
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 4 decision makers on Zeliq →

Organizational Chart of Phaxiam Therapeutics

Roles identified within Phaxiam Therapeutics's leadership team, based on public professional data.

Phaxiam Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Team Structure headcount by department

Research
10
Medical
4
Operations
4
Other
4
General Management
3
Finance
2
Technical
2
Education
1

Funding

Last round Other · $8M
Total funding $213M (14 rounds)
Series A $750K Nov 2005
Venture Round $12M Dec 2006
Series B $5M Jul 2010
Series C $4M Jul 2011
Post-IPO Equity $17M Apr 2013
Post-IPO Equity $30M Oct 2014
Post-IPO Equity $25M Dec 2015
Venture Round $70M Apr 2017
Post-IPO Equity N/A Nov 2017
Post-IPO Equity N/A Jan 2020
Post-IPO Debt $10M Nov 2020
Post-IPO Equity $30M Apr 2021
Corporate Round N/A Jun 2023
Post-IPO Equity $8M Jun 2024

Companies similar to Phaxiam Therapeutics

About Phaxiam Therapeutics

Phaxiam Therapeutics operates in the Biotechnology industry, operating from France. The company was founded in 2004 and counts about 200 employees. Phaxiam Therapeutics belongs to the Hospitals and Health Care sector, with a specific positioning on Biotechnology. Phaxiam Therapeutics is a B2B company, primarily serving business clients and professional organisations. Phaxiam Therapeutics has raised funding across 14 rounds totalling $213M. Sales teams can rely on this profile to qualify Phaxiam Therapeutics, spot business signals, and connect with verified decision makers.

Activity & Market

Phaxiam Therapeutics operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Phaxiam Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.

How to prospect Phaxiam Therapeutics's departments

Research

This is where the company's largest headcount sits (10 people). Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Medical

With 4 people, this is the organisation's second pillar. Medical teams trust peer references: name comparable organisations you already serve.

Operations

4 people work in this department. Process efficiency and cost control are the angles that resonate with these decision makers.

Other

A team of 4 people. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

General Management

This department counts 3 people. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Finance

2 people work in this department. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

FAQ Phaxiam Therapeutics

What industry does Phaxiam Therapeutics operate in?

Phaxiam Therapeutics is active in the Biotechnology industry, specifically in the Hospitals and Health Care category.

How many employees does Phaxiam Therapeutics have?

Phaxiam Therapeutics has approximately 200 employees (in the 51-200 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Phaxiam Therapeutics?

Zeliq lets you identify decision makers at Phaxiam Therapeutics, enrich their professional contact details (verified emails and direct phone numbers), and launch targeted multichannel prospecting sequences.

Where is Phaxiam Therapeutics headquartered?

Phaxiam Therapeutics is headquartered in France.

What is the organizational chart of Phaxiam Therapeutics?

Roles identified within Phaxiam Therapeutics's organization include CEO, Directeur Général Délégué, VP Corporate Development. With Zeliq, you can enrich each of these roles with verified emails and direct phone numbers.

Why use this data before prospecting Phaxiam Therapeutics?

Industry, headcount and business signals give you the context to qualify Phaxiam Therapeutics, tailor your messaging, and focus your effort on the right decision makers.